1943
DOI: 10.1039/jr9430000079
|View full text |Cite
|
Sign up to set email alerts
|

Notes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
31
0
1

Year Published

1970
1970
2011
2011

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(32 citation statements)
references
References 0 publications
0
31
0
1
Order By: Relevance
“…100 C for 6 h gave the title compound 3d (906 mg, 93%) as colourless needles, mp 102e103 C (lit., 29 103e105 C) (cyclohexane); R f (t-BuOMe) 0.86; l max (DCM)/nm 233 (log 3 4.27), 278 (3.92); n max /cm À1 3449w (NH 2 ), 3292w, 3123w, 3055w, 2918w, 2860w, 1633s, 1601m, 1568m, 1504m, 1447w, 1383m, 1234m, 1105w, 1024w, 926w, 866m, 793m, 777m, 758w, 714m; 124.5e125 C (lit., 21 126e128 C) (cyclohexane/EtOH, 95:05); R f (tBuOMe) 0.57; l max (DCM)/nm 231 (log 3 4.23), 278 (3.83); n max /cm À1 3470w and 3344w (NH 2 ), 3202w (Ar CH), 1614s,1570m,1499s,1473w, 1445w, 1410w, 1379m, 1238w, 1213s, 1092w, 1076w, 1028w, 1011w, 979w, 928w, 862w, 851w, 802w, 779m, 762s, 706s; and 4-chloroaniline (500 mg, 3.92 mmol) heated at ca. 100 C for 6 h gave the title compound 3f (807 mg, 89%) as colourless needles, mp 116.5 C (lit., 27 (7), 214 (31), 169 (14), 149 (7), 147 (9), 129 (27), 127 (61), 113 (11), 111 (29), 104 (68), 97 (15), 77 (33), 69 (11), 51 (13) (15), 258 (19), 194 (7), 173 (50), 171 (53), 157 (15), 155 (17), 104 (100), 97 (28), 92 (15), 84 (11), 77 (58), 65 (11), 51 (28).…”
Section: General Methods and Materialsmentioning
confidence: 98%
See 1 more Smart Citation
“…100 C for 6 h gave the title compound 3d (906 mg, 93%) as colourless needles, mp 102e103 C (lit., 29 103e105 C) (cyclohexane); R f (t-BuOMe) 0.86; l max (DCM)/nm 233 (log 3 4.27), 278 (3.92); n max /cm À1 3449w (NH 2 ), 3292w, 3123w, 3055w, 2918w, 2860w, 1633s, 1601m, 1568m, 1504m, 1447w, 1383m, 1234m, 1105w, 1024w, 926w, 866m, 793m, 777m, 758w, 714m; 124.5e125 C (lit., 21 126e128 C) (cyclohexane/EtOH, 95:05); R f (tBuOMe) 0.57; l max (DCM)/nm 231 (log 3 4.23), 278 (3.83); n max /cm À1 3470w and 3344w (NH 2 ), 3202w (Ar CH), 1614s,1570m,1499s,1473w, 1445w, 1410w, 1379m, 1238w, 1213s, 1092w, 1076w, 1028w, 1011w, 979w, 928w, 862w, 851w, 802w, 779m, 762s, 706s; and 4-chloroaniline (500 mg, 3.92 mmol) heated at ca. 100 C for 6 h gave the title compound 3f (807 mg, 89%) as colourless needles, mp 116.5 C (lit., 27 (7), 214 (31), 169 (14), 149 (7), 147 (9), 129 (27), 127 (61), 113 (11), 111 (29), 104 (68), 97 (15), 77 (33), 69 (11), 51 (13) (15), 258 (19), 194 (7), 173 (50), 171 (53), 157 (15), 155 (17), 104 (100), 97 (28), 92 (15), 84 (11), 77 (58), 65 (11), 51 (28).…”
Section: General Methods and Materialsmentioning
confidence: 98%
“…100 C for 6 h gave the title compound 3h (622.5 mg, 85%) as colourless needles, mp 137 C (lit., 30 139 C) (cyclohexane/EtOH, 95:05); R f (t-BuOMe) 0.86; l max (DCM)/nm 231 (log 3 4.91), 246 (5.03), 280 inf (4.70); n max / cm À1 3470w and 3345w (NH 2 ), 3071 (Ar CH), 1612s, 1568s, 1481w, 1470w, 1447w, 1396w, 1375m, 1298w, 1238m, 1177w, 1101w, 1076w, 1063w, 1001m, 858m, 777m, 717m, 704s; 3.09 mmol) and 3,4-dichloroaniline (500 mg, 3.09 mmol) heated at ca. 100 C for 6 h gave the title compound 3i (746 mg, 91%) as colourless plates, mp 108e109 C (lit., 6b 110e111 C) (cyclohexane/ EtOH, 95:05); R f (t-BuOMe) 0.79; l max (DCM)/nm 231 (log 3 4.46), 246 (4.43), 285 (4.13); n max /cm À1 3449w and 3326w (NH 2 ), 1614s, 1568s, 1470m, 1458m, 1387m, 1371m, 1227w, 1128m, 1024m, 930w, 897m, 3495m, 3453w and 3395m (NH 2 ), 3277w, 1632s, 1576m, 1574m, 1547m, 1495w, 1468m, 1450m, 1387s, 1375m, 1321m, 1261w, 1252m, 1223w, 1157w, 1119m, 1020w, 889s, 852m, 835m, 771m, 750s, 717w; 6,148.3,147.7,133.0,131.6 (CH) (17), 208 (2), 192 (3), 163 (28), 161 (49), 119 (100), 92 (29), 75 (5), 65 (22).…”
Section: General Methods and Materialsmentioning
confidence: 99%
“…ZnCl 2 (Aldrich) was dried under reduced pressure and used as a THF solution prepared prior to use. CuI [68], CuBr [69], CuCl [69], CuCN [70] and CuSCN [68] were purified according to the published procedures. n-Butylmagnesium bromide n-BuMgBr (1) was prepared in THF according to standard procedure and its concentration was found by titration prior to use [71].…”
Section: Generalmentioning
confidence: 99%
“…Für NEt4CN, Hg(CN)2 und NaCN wurden Präparate der Firma Fluka ver wendet. LiCN wurde nach dem Verfahren von Rossmanith [11], CuCN nach Barber [12] dargestellt.…”
Section: Experimentellesunclassified